An ingestible gastrointestinal capsule (GIC) for mechanically stimulating a segment of the gastrointestinal (Gl) wall by alternately and repeatedly pressurizing, and/or vibrating it is provided. The GIC is programmed to being activated following a predefined time delay. The activated GIC agitates, shakes, rattles, j...
An ingestible gastrointestinal capsule (GIC) for mechanically stimulating a segment of the gastrointestinal (Gl) wall by alternately and repeatedly pressurizing, and/or vibrating it is provided. The GIC is programmed to being activated following a predefined time delay. The activated GIC agitates, shakes, rattles, j...
A gastrointestinal treatment system including a gastrointestinal capsule adapted to treat a subject following ingestion of the gastrointestinal capsule. The gastrointestinal capsule includes: (a) a housing; (b) a vibrating agitation mechanism, powered by the battery, the vibrating agitation mechanism adapted such th...
Devices and methods for delivering an ingestible medicament of a medicament tablet into the gastrointestinal tract of a user. A device according to the invention includes a vibrating ingestible capsule and a hollow medicament compartment housing. The vibrating capsule includes a housing, a vibrating agitation mechan...
A vibrating ingestible capsule includes a housing having a longitudinal axis, and having a vibrating agitation mechanism adapted such that, in a first vibrating mode of operation, the housing exerts vibrations on an environment surrounding the capsule. A power supply disposed within the housing is adapted to power t...
A device and a method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user. The device includes a vibrating ingestible capsule attached to, or including, a medicament delivery compartment. The medicament delivery compartment includes a housing including a portal, a medicament res...
A system and a method for treatment of a disorder in a gastrointestinal tract of a subject, using a treatment protocol, the treatment protocol being based at least in part on data relating to other subjects and their responses to treatment with various treatment protocols.
Documents
Form DPT-3-25092020-signed
Form AOC-4-18122019_signed
Form MGT-7-16122019_signed
List of share holders, debenture holders;-12122019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-12122019
Statement of Subsidiaries as per section 129 - Form AOC-1-12122019
Directors report as per section 134(3)-12122019
Form ADT-1-24102019_signed
Copy of written consent given by auditor-17102019
Copy of resolution passed by the company-17102019
Form DPT-3-31072019
Optional Attachment-(1)-31072019
Optional Attachment-(1)-30062019
Form ADT-1-13062019_signed
Copy of the intimation sent by company-13062019
Copy of resolution passed by the company-13062019
Copy of written consent given by auditor-13062019
Form MGT-7-04032019_signed
Form AOC-4-01032019_signed
List of share holders, debenture holders;-25022019
Directors report as per section 134(3)-22022019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-22022019
Form AOC-4-30112016_signed
Directors report as per section 134(3)-29112016
Statement of Subsidiaries as per section 129 - Form AOC-1-29112016
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29112016
Form MGT-7-29112016_signed
List of share holders, debenture holders;-28112016